L-DOPA, catecholamines, and behavior: a clinical and biochemical study in depressed patients.
D000368:Aged; D000374:Aggression / Q000187:drug effects; D000786:Anger / Q000187:drug effects; D001519:Behavior / Q000187:drug effects; D001714:Bipolar Disorder / Q000139:chemically induced; D001921:Brain / Q000378:metabolism*; D001923:Brain Chemistry; D002262:Carboxy-Lyases / Q000037:antagonists & inhibitors; D002395:Catecholamines / Q000032:analysis / Q000378:metabolism / Q000627:therapeutic use* / Q000652:urine; D002540:Cerebral Cortex / Q000187:drug effects; D002986:Clinical Trials as Topic; D003863:Depression / Q000188:drug therapy* / Q000652:urine; D004064:Digestive System / Q000187:drug effects; D004295:Dihydroxyphenylalanine / Q000008:administration & dosage* / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use* / Q000652:urine; D005071:Evoked Potentials / Q000187:drug effects; D005260:Female; D006439:Hemodynamics / Q000187:drug effects; D006801:Humans; D008297:Male; D008996:Monoamine Oxidase Inhibitors / Q000494:pharmacology; D010300:Parkinson Disease / Q000188:drug therapy; D010919:Placebos; D012110:Reserpine / Q000494:pharmacology; D012890:Sleep / Q000187:drug effects
D002395:Catecholamines; D008996:Monoamine Oxidase Inhibitors; D010919:Placebos; D004295:Dihydroxyphenylalanine; D012110:Reserpine; D002262:Carboxy-Lyases